Skip to content
ppharmaranks
Menu

vostally

Vostally (Ramipril) is an angiotensin converting enzyme inhibitor used to treat Diabetic Nephropathies, Heart Failure, Hypertension, Left Ventricular Dysfunction.

Ramipril · by Rosemont

Not yet rated· sourced from the FDA label
Rated against independent regulatory sources·Last updated June 7, 2026·How we rate
Verified againstopenFDANIH DailyMedRxClass
~$1.71 /30
Compare online visit prices →We may earn a commission · never affects ratings
Lower-cost optionsSave up to 56%
This medication~$1.71/30
Cheapest in class · qbrelis~$0.76/30
See FDA-approved alternatives

Key facts

Active ingredient
Ramipril
Form
Solution
Strength
Ramipril 1MG/ML
Type
Prescription (Rx)
Brand or generic
Brand-name
Manufacturer
Rosemont
What the pharmacy pays
~$1.71 for 30 — not your price
FDA application
NDA219757
Availability
Discontinued (per FDA)

Foods & drinks to be careful with

Well-established interactions for this medicine’s drug class, summarized from public health authorities. General information, not medical advice — always confirm with your pharmacist or the label.

Drug class

May treat (source: NIH RxClass)

See how Vostally ranks — best-rated angiotensin converting enzyme inhibitor for:

Dosage forms

Solution

The forms currently marketed in the U.S., per the FDA National Drug Code Directory.

Ways to save

Ask for the generic

Same active ingredient, far cheaper. Is there a generic? →

Request a 90-day supply

Bulk fills usually lower the per-dose price vs monthly refills.

Use copay cards

Manufacturer copay cards & patient-assistance programs — especially for brand drugs.

Compare alternatives

A same-class option may cost less. See alternatives →

Frequently asked questions

What does Vostally treat?
Vostally (Ramipril) may be used to treat diabetic nephropathies, heart failure, hypertension, left ventricular dysfunction, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
How much does Vostally cost?
Nobody can tell you what you will pay — your price is set by your insurer's formulary, your deductible and the pharmacy's markup, and none of those are published. What IS published is what the pharmacy paid to acquire it: about $1.71 for 30, per the CMS NADAC survey. Treat that as the floor, not the quote — ask the pharmacist for the cash price as well as your copay, because for cheap generics the cash price often wins. Pharmacies pay less for a same-class option, Qbrelis — about $0.76 on the same basis.
Is there a coupon or discount for Vostally?
pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Vostally. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
Who makes Vostally?
Vostally is marketed by Rosemont. You can see Rosemont's full profile, rating, and other products on pharmaranks.
Is Vostally a brand-name or generic drug?
Vostally is a brand-name product with the active ingredient Ramipril.
Is Vostally available over the counter?
No. Vostally is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
What forms does Vostally come in?
Vostally is currently marketed as solution, per the FDA's National Drug Code Directory.
What class of drug is Vostally?
Vostally is classified as angiotensin converting enzyme inhibitor, per the FDA's Established Pharmacologic Class.
Is Vostally FDA-registered?
Vostally is on record with the U.S. FDA under application number NDA219757. You can verify this on its official FDA label.

Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.

What people report to the FDA about RAMIPRIL

The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 131,316 reports naming RAMIPRIL — the active ingredient in Vostally, and the FDA flagged 94% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:

  • dyspnoea8,863 reports
  • fatigue8,612 reports
  • nausea7,944 reports
  • diarrhoea7,542 reports
  • dizziness7,166 reports
  • vomiting6,585 reports
  • acute kidney injury5,928 reports
  • headache5,891 reports

Read these as a signal, not a rate. A report does not mean RAMIPRIL caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.

Source: openFDA drug/event (FAERS), retrieved September 26, 2026.

Reviews

No reviews yet. Be the first to write one.

Write a review

Reviews are user opinions, not medical advice. Consult a licensed professional.

People also viewed

Compare Vostally head-to-head

Guides for this medication

Identify a pill by its imprint →Check a drug interaction →Drug recalls →

Browse medications A–Z

Research products from A to Z, compare independent ratings, and find alternatives.